CORCEPT THERAPEUTICS INC: total assets
Total assets for CORCEPT THERAPEUTICS INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All CORCEPT THERAPEUTICS INC financial histories
What this measure means
Resources recognized on the balance sheet. Book assets are not the market value of the business.
Exact concept: us-gaap:Assets. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 836,651,000 | USD | 2026-02-24 | 10-K · 0001628280-26-011091 |
| At date | 2024-12-31 | 840,553,000 | USD | 2026-02-24 | 10-K · 0001628280-26-011091 |
| At date | 2023-12-31 | 621,517,000 | USD | 2025-02-26 | 10-K · 0001628280-25-008167 |
| At date | 2022-12-31 | 583,430,000 | USD | 2024-02-15 | 10-K · 0001628280-24-005055 |
| At date | 2021-12-31 | 423,756,000 | USD | 2023-02-28 | 10-K · 0001628280-23-005581 |
| At date | 2020-12-31 | 571,731,000 | USD | 2022-02-15 | 10-K · 0001628280-22-002714 |
| At date | 2019-12-31 | 412,312,000 | USD | 2021-02-23 | 10-K · 0001628280-21-002861 |
| At date | 2018-12-31 | 311,694,000 | USD | 2020-02-24 | 10-K · 0001628280-20-002122 |
| At date | 2017-12-31 | 220,537,000 | USD | 2019-02-26 | 10-K · 0001628280-19-001879 |
| At date | 2016-12-31 | 68,753,000 | USD | 2018-02-28 | 10-K · 0001564590-18-003840 |
| At date | 2015-12-31 | 51,902,000 | USD | 2017-03-06 | 10-K · 0001564590-17-003493 |
| At date | 2014-12-31 | 34,630,000 | USD | 2016-03-10 | 10-K · 0001088856-16-000011 |
| At date | 2013-12-31 | 63,077,000 | USD | 2015-03-13 | 10-K · 0001562762-15-000080 |
| At date | 2012-12-31 | 99,166,000 | USD | 2014-03-14 | 10-K · 0001193125-14-100313 |
| At date | 2011-12-31 | 39,833,000 | USD | 2013-03-15 | 10-K · 0001193125-13-110085 |
| At date | 2010-12-31 | 25,104,000 | USD | 2012-03-13 | 10-K · 0001193125-12-112317 |
Related financial histories
- CORCEPT THERAPEUTICS INC: total liabilities
- CORCEPT THERAPEUTICS INC: stockholders equity
- CORCEPT THERAPEUTICS INC: cash and cash equivalents
- CORCEPT THERAPEUTICS INC: net income or loss
- CORCEPT THERAPEUTICS INC: operating cash flow
- CORCEPT THERAPEUTICS INC: capital expenditure payments
- CORCEPT THERAPEUTICS INC: contract revenue excluding tax
- CORCEPT THERAPEUTICS INC: financing cash flow
- CORCEPT THERAPEUTICS INC: investing cash flow
- CORCEPT THERAPEUTICS INC: retained earnings or deficit
- CORCEPT THERAPEUTICS INC: basic weighted-average shares
- CORCEPT THERAPEUTICS INC: diluted weighted-average shares
- CORCEPT THERAPEUTICS INC: basic earnings per share
- CORCEPT THERAPEUTICS INC: diluted earnings per share
- CORCEPT THERAPEUTICS INC: income tax expense or benefit
- CORCEPT THERAPEUTICS INC: net property, plant and equipment
- CORCEPT THERAPEUTICS INC: share-based compensation expense
- CORCEPT THERAPEUTICS INC: operating income or loss
- CORCEPT THERAPEUTICS INC: current assets
- CORCEPT THERAPEUTICS INC: current liabilities
- CORCEPT THERAPEUTICS INC: current accounts payable
- CORCEPT THERAPEUTICS INC: net current accounts receivable
- CORCEPT THERAPEUTICS INC: common-stock repurchase payments
- CORCEPT THERAPEUTICS INC: operating expenses
- CORCEPT THERAPEUTICS INC: net inventory
- CORCEPT THERAPEUTICS INC: cost of revenue
- CORCEPT THERAPEUTICS INC: selling, general and administrative expense
- CORCEPT THERAPEUTICS INC: research and development expense
Inspect the source
- Entity
- CORCEPT THERAPEUTICS INC / CIK 0001088856
- Captured
- 2026-09-20T05:21:37.067Z
- SEC response SHA-256
9eeefb4ce187c5355b174f4fe6f87e573e0565fb0941138bcb8d7151ae198435
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001088856.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))